CASE Op-Ed in RealClear Health: One-Size-Fits-All Is Not a Good Fit in Medicine
In the wake of the COVID-19 pandemic, the CDC’s role in public health crises remains under enormous scrutiny, especially...
CASE Rejects Senate Political Show-Trial Attacking Miracle Drugs Ozempic & Wegovy
September 24, 2024 The Honorable Bernie Sanders, Chairman United States Senate Committee on Health, Education, Labor and Pensions 428 Dirksen...
College Freedom Project: Five Higher Education Policy Priorities for 2024
The United States has a vibrant higher education system that offers students of all backgrounds an opportunity to earn a...
Higher Ed on the Hill: Chairwoman Foxx Aims to Bring Accountability Back to Colleges
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. In...
Higher Ed on the Hill: Taking on the Gainful Employment Rule
Welcome back to Higher Ed on the Hill where we break down the top issues driving higher education policy. Up...
CASE Op-Ed in RealClear Policy: DC Bureaucrats Micromanaging the Internet Hurts Consumers and Threatens Freedom
November 14, 2023 Six years ago, when the FCC wisely ended its brief dalliance with regulating the internet under...
Usage-Based Billing is Key to Lower Costs and More Broadband Data for Consumers
September 1, 2023 In a typical free-market economy, consumers accept without a second thought that different items carry different...
CASE Op-Ed in The DC Journal: Attacks on Nurse-Hiring Agencies Are a Broadside Against the Sick
July 25, 2023 An alarming crisis is looming on our healthcare horizon, with forecasts of a mass nursing exodus...
CASE Op-Ed in RealClear Markets: Consumers Would Pay the Price For the CFPB’s ‘Late Fee’ Overreach
May 2, 2023 Washington insiders insist there is no truth to the rumor that Jimmy Carter lamented his record...
CASE Op-Ed in DC Journal: Attempting to Stymie the Future of Travel
April 25, 2023 For most consumers, booking an airline ticket is a matter of clicking or scrolling through online...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/